Mechanistically, it has been demonstrated that LINC01087 participates in the development of glioma by targeting some microRNAs (miRNAs) (i.e., miR-384 and miR-1277-5p) and, therefore, altering the related signaling pathways [36,37]. Here, LINC01087 is linked to central nervous system cancer.